Validation of MMS Test for Cancer Monitoring

MedInnovation GmbH100 enrolled

Overview

The purpose of this study is the validation of MMS test to detect active tumor growth in different cancer types before and after therapy, as well as in the course of therapy and for subsequent relapse control compared to standard methods (clinical examination, imaging, tumor markers). It should be consider whether the MMS test has comparable diagnostic accuracy, and thus can replace more expensive or invasive procedures in future.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Colo-rectal Cancer Stomach Cancer Melanoma Sarcoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of colo-rectal cancer * Clinical diagnosis of stomach cancer * Suspected diagnosis of melanoma Exclusion Criteria: * Colitis ulcerosa * Morbus Crohn * Cancer in time period two years before * Cancer therapy in time period two years before

Locations (1)

HELIOS Klinikum Berlin-Buch, Klinik für Interdisziplinäre Onkologie

Berlin, Germany

Outcomes

Primary Outcomes

active tumor growth before and after cancer therapy

Time frame: up to 36 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.